Skip to main content
SpringerLink
Log in

A Controlled Study of Alprostadil Liposomal Preparation in the Treatment of Blue Toe Syndrome

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

The aim of this study is to examine the efficacy of alprostadil liposomal preparation in the treatment of blue toe syndrome. As many as 32 patients with blue toe syndrome were randomized into the test group and a control group. Patients out of the test group were treated with alprostadil liposomal preparation, while those out of the control group received placebo administration. Inter-group comparisons were conducted for the post-therapeutic changes of microcirculation and improvements of clinical symptoms. In the test group, there were eight subjects with marked response (50.0 %), six subjects with partial response (37.5 %), and two subjects with no response (12.5 %), with the overall response rate of 87.5 %. In the control group, there were three cases (18.8 %), one case (6.4 %), and 12 cases (75 %), respectively, with the overall response rate of 25.0 %. The inter-group difference of response was statistically significant (Χ 2 = 12.987, P = 0.002 < 0.05). In the test group, there was one case of administration site redness which could be resolved spontaneously. No other adverse drug reactions were reported. No any complaints were reported for the control group. The inter-group difference of nail-fold microcirculation was not statistically significant (P > 0.05). The post-therapeutic points of nail-fold microcirculation in the test group decreased significantly (P < 0.05), but no significant changes were observed for the control group (P > 0.05). The post-therapeutic waveform changes of photoelectric plethysmography were significant for the test group in comparison to the control. The safety and efficacy of alprostadil liposomal preparation have been demonstrated in the treatment of blue toe syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Fang, W., Guo, S. G., Chen, C. J., et al. (2006). Diagnosis and treatment of blue tou syndrome (with one case report and literature review). China Journal of Modern Medicine, 16(14), 2239–2240.

  2. Luo, T., Zhang, J., Chen, B., et al. (2009). Efficacy and safety of homemade lipoprostagladin E1 injection in treatment of peripheral arterial occlusive disease. Adverse Drug Reactions Journal, 11(5), 310–314.

    Google Scholar 

  3. Zhang, W., Li, K., Zhang, Y., et al. (2000). Detection of aortic athersclerotic plaques in patients with blue toe syndrome. Chinese Journal of Ultrasonography, 9(3), 27–29.

    CAS  Google Scholar 

  4. Zhao, Z., Wang, L., Pan, S. X., et al. (2010). Measurement principles and development of cardiac output monitoring. Chinese Journal of Biomedical Engineering, 29(4), 620–626.

    Google Scholar 

  5. Tian, N., et al. (2011). Editor in chief, circulation, basis and clinical practice. Beijing: Atomic Energy Press.

  6. Chen, B. N., et al. (2012).Integrative Medicine Science for Peripheral Vascular Disease. Beijing: China Press of Traditional Chinese Medicine.

  7. Postema, P. G., Regeer, M. V., van der Valk, P. R., et al. (2010). Blue toe syndrome and sunitinib. International Journal of Clinical Oncology/Japan Society of Clinical Oncology, 16(5), 574–576.

    Article  Google Scholar 

  8. Hirschmann, J. V., & Raugi, G. J. (2009). Blue (or purple) toe syndrome. Journal of the American Academy Of Dermatology, 60(1), 1–20. quiz 21–22.

    Article  PubMed  Google Scholar 

  9. Radauceanu, A., Avignon, A., Ribstein, J., et al. (1998). Use of a prostacyclin analogue in cholesterol crystal embolism. Diabetic Medicine, 15, 262–263.

    Article  CAS  PubMed  Google Scholar 

  10. Ziche, M., Morbidelli, L., Parenti, A., et al. (1995). Nitric oxide modulates angiogenesis elicited by prostaglandin E1 in rabbit cornea. Advances in Prostaglandin, Thromboxane, and Leukotriene Research, 23, 495–497.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical College, Affiliated Hospital of Southeast University, Xuzhou, 221009, Jiangsu, China

    Hai-lin Xi, Zhi-long Tian, Su Feng & Gao-Lei Jia

  2. Department of Central Laboratory, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical College, Affiliated Hospital of Southeast University, Xuzhou, 221009, Jiangsu, China

    Rui Li

Authors
  1. Hai-lin Xi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rui Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhi-long Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Su Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gao-Lei Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhi-long Tian.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xi, Hl., Li, R., Tian, Zl. et al. A Controlled Study of Alprostadil Liposomal Preparation in the Treatment of Blue Toe Syndrome. Cell Biochem Biophys 72, 265–268 (2015). https://doi.org/10.1007/s12013-014-0448-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-014-0448-9

Keywords

Search

Navigation